| Comparative effectiveness of bivalent BA. 4-5 and BA. 1 mRNA booster vaccines among adults aged≥ 50 years in Nordic countries: nationwide cohort study NW Andersson, EM Thiesson, U Baum, N Pihlström, J Starrfelt, K Faksová, ... bmj 382, 2023 | 67 | 2023 |
| COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals K Faksova, D Walsh, Y Jiang, J Griffin, A Phillips, A Gentile, JC Kwong, ... Vaccine 42 (9), 2200-2211, 2024 | 48 | 2024 |
| Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses NW Andersson, EM Thiesson, U Baum, N Pihlström, J Starrfelt, K Faksová, ... bmj 382, 2023 | 15 | 2023 |
| Nutritionally adequate food baskets optimised for cultural acceptability as basis for dietary guidelines for low-income Czech families K Faksová, ZD Brázdová, A Robertson, A Parlesak Nutrition journal 18 (1), 84, 2019 | 13 | 2019 |
| Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries NW Andersson, EM Thiesson, U Baum, N Pihlström, J Starrfelt, K Faksová, ... MedRxiv, 2022.11. 24.22282651, 2022 | 2 | 2022 |
| D2. 4 Report on identification of adverse events for safety evaluations of RSV vaccination and monoclonal antibodies K Faksova, L Marcelon, D Neveu, S Li, MM Lino, TT Htar, T Heikkinen, ... | | 2024 |
| Comparative effectiveness of the monovalent XBB. 1.5-containing covid-19 mRNA vaccine across three Nordic countries NW Andersson, EM Thiesson, N Pihlstrom, J Perala, K Faksova, MA Gram, ... medRxiv, 2024.05. 08.24307058, 2024 | | 2024 |
